MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

AngioDynamics Inc

Затворен

СекторЗдравеопазване

9.84 -9.39

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

9.64

Максимум

10.86

Ключови измерители

By Trading Economics

Приходи

2.7M

-11M

Продажби

1.9M

73M

EPS

-0.04

Марж на печалбата

-14.741

Служители

748

EBITDA

3.8M

1.8M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+41.16% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

107M

384M

Предишно отваряне

19.23

Предишно затваряне

9.84

Настроения в новините

By Acuity

38%

62%

139 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

AngioDynamics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.12.2024 г., 15:23 ч. UTC

Значими двигатели на пазара

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9.12.2024 г., 15:20 ч. UTC

Значими двигатели на пазара

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

4.04.2024 г., 14:56 ч. UTC

Печалби
Значими двигатели на пазара

AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Сравнение с други в отрасъла

Ценова промяна

AngioDynamics Inc Прогноза

Ценова цел

By TipRanks

41.16% нагоре

12-месечна прогноза

Среден 15.33 USD  41.16%

Висок 16 USD

Нисък 15 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за AngioDynamics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

9.87 / N/AПодкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Weak Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Настроение

By Acuity

139 / 386 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.